Cargando…

Carbon Ion Radiotherapy Induce Metabolic Inhibition After Functional Imaging-Guided Simultaneous Integrated Boost for Prostate Cancer

PURPOSE: As local recurrence remains a challenge and the advantages of the simultaneous integrated boost (SIB) technique have been validated in photon radiotherapy, we applied the SIB technique to CIRT. The aim was to investigate the metabolomic changes of the CIRT with concurrent androgen deprivati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pei, Yulei, Ning, Renli, Hu, Wei, Li, Ping, Zhang, Zhenshan, Deng, Yong, Hong, Zhengshan, Sun, Yun, Guo, Xiaomao, Zhang, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354483/ https://www.ncbi.nlm.nih.gov/pubmed/35936669 http://dx.doi.org/10.3389/fonc.2022.845583

Ejemplares similares

Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer
por: Hu, Wei, et al.
Publicado: (2022)

Functional imaging-guided carbon ion irradiation with simultaneous integrated boost for localized prostate cancer: study protocol for a phase II randomized controlled clinical trial
por: Hu, Wei, et al.
Publicado: (2022)

Carbon Ion Radiotherapy Evokes a Metabolic Reprogramming and Individualized Response in Prostate Cancer
por: Ning, Renli, et al.
Publicado: (2021)

The metabolic repression effect of carbon-ion radiotherapy in synchronous hormone-sensitive oligometastatic prostate cancer
por: Zhang, Zhenshan, et al.
Publicado: (2023)

Biological and clinical significance of radiomics features obtained from magnetic resonance imaging preceding pre-carbon ion radiotherapy in prostate cancer based on radiometabolomics
por: Zhang, Guangyuan, et al.
Publicado: (2023)

Two-Year Toxicity and Efficacy of Carbon Ion Radiotherapy in the Treatment of Localized Prostate Cancer: A Single-Centered Study
por: Li, Ping, et al.
Publicado: (2022)

In Silico Feasibility Study of Carbon Ion Radiotherapy With Simultaneous Integrated Boost for Head and Neck Adenoid Cystic Carcinoma
por: Mastella, Edoardo, et al.
Publicado: (2021)

Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma
por: Adeberg, Sebastian, et al.
Publicado: (2019)

Landscape of Carbon Ion Radiotherapy in Prostate Cancer: Clinical Application and Translational Research
por: Chen, Xue, et al.
Publicado: (2021)

Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer
por: Stoian, Raluca, et al.
Publicado: (2023)

Radiotherapy planning in a prostate cancer phantom model with intraprostatic dominant lesions using stereotactic body radiotherapy with volumetric modulated arcs and a simultaneous integrated boost
por: Skrobala, Agnieszka, et al.
Publicado: (2023)

Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer
por: Maruyama, Katsuya, et al.
Publicado: (2017)

The Emerging Role of Carbon-Ion Radiotherapy
por: Ebner, Daniel K., et al.
Publicado: (2016)

Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300
por: Marvaso, Giulia, et al.
Publicado: (2021)

MR-Guided Radiotherapy for Prostate Cancer
por: Tocco, Boris R., et al.
Publicado: (2020)

Clinical Efficacy and Safety of Proton and Carbon Ion Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis
por: Li, Meixuan, et al.
Publicado: (2021)

Evaluation of Safety for Scanning Carbon-Ion Radiotherapy in Hemodialysis Patients With Prostate Cancer
por: Takakusagi, Yosuke, et al.
Publicado: (2022)

Flourish of Proton and Carbon Ion Radiotherapy in China
por: Li, Yue, et al.
Publicado: (2022)

The Early Result of Whole Pelvic Radiotherapy and Stereotactic Body Radiotherapy Boost for High-Risk Localized Prostate Cancer
por: Lin, Yu-Wei, et al.
Publicado: (2014)

Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model
por: Wang, Weiwei, et al.
Publicado: (2021)

Clinical trial of carbon ion radiotherapy for gynecological melanoma
por: Karasawa, Kumiko, et al.
Publicado: (2014)

Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300)
por: Russo, Stefania, et al.
Publicado: (2021)

Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer
por: Wang, Shih-Chang, et al.
Publicado: (2020)

The Efficacy and Safety of Carbon Ion Radiotherapy for Meningiomas: A Systematic Review and Meta-Analysis
por: Li, Jie-yun, et al.
Publicado: (2021)

Carbon Ion Radiotherapy for Patients with Extracranial Chordoma or Chondrosarcoma - Initial Experience from Shanghai Proton and Heavy Ion Center
por: Wu, Shuang, et al.
Publicado: (2019)

Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated Boost
por: van Schie, Marcel A., et al.
Publicado: (2019)

Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost
por: Laughlin, Brady S., et al.
Publicado: (2022)

Dosimetric and Radiobiological Comparison of External Beam Radiotherapy Using Simultaneous Integrated Boost Technique for Esophageal Cancer in Different Location
por: Wang, Lu, et al.
Publicado: (2019)

Carbon-ion Radiotherapy for Isolated Lymph Node Metastasis After Surgery or Radiotherapy for Lung Cancer
por: Shirai, Katsuyuki, et al.
Publicado: (2019)

A RapidArc planning strategy for prostate with simultaneous integrated boost
por: Jolly, David, et al.
Publicado: (2010)

Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Drug-Resistant Gastrointestinal Stromal Tumors: A Feasibility Study
por: Li, Longhao, et al.
Publicado: (2020)

Clinical Implication of Simultaneous Intensity-modulated Radiotherapy Boost to Tumor Bed for Cervical Cancer with Full-thickness Stromal Invasion
por: Zhang, Zongkai, et al.
Publicado: (2022)

Definitive Simultaneous Integrated Boost Versus Conventional-Fractionated Intensity Modulated Radiotherapy for Patients With Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis
por: Li, Chen, et al.
Publicado: (2021)

Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma
por: Hu, Jiyi, et al.
Publicado: (2021)

Impact of Inter-fractional Anatomical Changes on Dose Distributions in Passive Carbon-Ion Radiotherapy for Prostate Cancer: Comparison of Vertical and Horizontal Fields
por: Yokoyama, Ayaka, et al.
Publicado: (2020)

Investigation of Suitable Detection Angles for Carbon-Ion Radiotherapy Monitoring in Depth by Means of Secondary-Ion Tracking
por: Ghesquière-Diérickx, Laura, et al.
Publicado: (2021)

MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
por: Ménard, Cynthia, et al.
Publicado: (2022)

Hypofractionated Image-Guided Radiation Therapy With Simultaneous-Integrated Boost Technique for Limited Metastases: A Multi-Institutional Analysis
por: Jacobs, Corbin D., et al.
Publicado: (2019)

Carbon ion radiotherapy using fiducial markers for prostate cancer in Osaka HIMAK: Treatment planning
por: Tsubouchi, Toshiro, et al.
Publicado: (2021)

Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate cancer
por: Hsu, Shu-Hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_56829ulnut9d2lv7lbuiae4atp